The DNA Diagnostics Market is set to surge from USD 13.07 billion in 2024 to USD 21.69 billion by 2030, growing at a CAGR of 8.81%. Key trends driving this growth include the emergence of liquid ...

The cost of decoding our genetic makeup has plummeted. Just because it’s affordable doesn’t necessarily mean it’s worth doing ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

A large Mayo Clinic study shows that current guidelines fail to detect nearly 90% of people with familial ...

Cancer involves more than just genetic mutations; it also involves structural failures. Consider a city where roads disappear, isolating communities from vital resources.

The United States DNA polymerase market is projected to reach USD 246.9 million by 2035, supported by rising investments in ...

Tuberculosis (TB) is one of the oldest and deadliest infectious diseases we know. It commonly impacts the lungs, but can also affect other areas of the body like the spine, brain or kidneys.

North America currently leads the DNA Synthesis Market due to its mature biotech ecosystem, heavy investment in genomics, and ...

Two University of Wisconsin researchers Edgar Spalding and Takeshi Yoshihara recently published a study concluding that there ...

A team from the Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER) has developed an innovative ...

Computational biology expert Nadia Lanman helps cancer researchers find solutions in massive datasets generated through ...